Why Are Shares of Globe Life (GL) Down Today?

This afternoon we watched Globe Life drop -1.5% to a price of $108.45 per share. The Large-Cap Life Insurance company is now trading -21.34% below its average target price of $137.88. Analysts have set target prices ranging from $125.0 to $160.0 per share for Globe Life, and have given the stock an average rating of buy.

Globe Life's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 2.8%. The stock's short ratio is 3.08. The company's insiders own 2.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 83.6%. In conclusion, we believe there is positive market sentiment regarding Globe Life.

Institutions Invested in Globe Life

Date Reported Holder Percentage Shares Value
2023-12-31 Vanguard Group Inc 12% 10,829,098 $1,174,415,645
2023-12-31 Blackrock Inc. 7% 6,695,726 $726,151,464
2023-12-31 Wellington Management Group, LLP 5% 4,685,657 $508,159,487
2023-12-31 JP Morgan Chase & Company 5% 4,335,817 $470,219,340
2023-12-31 State Street Corporation 4% 3,869,956 $419,696,716
2023-12-31 FMR, LLC 3% 3,009,395 $326,368,878
2023-12-31 Cooke & Bieler LP 3% 2,357,839 $255,707,632
2023-12-31 Geode Capital Management, LLC 2% 2,036,825 $220,893,665
2023-12-31 Boston Partners 2% 1,967,069 $213,328,627
2023-12-31 Invesco Ltd. 2% 1,756,177 $190,457,390
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.